Status:
COMPLETED
Contribution of Drug Induced Sleep Endoscopy of Pediatric Obstructive Sleep Apnea Hypopnea Syndrome
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Obstructive Sleep Apnea Hypopnea Syndrome
Eligibility:
All Genders
Up to 12 years
Brief Summary
The role of drug-induced sleep endoscopy (DISE) in the management of obstructive sleep apnea hypopnea syndrome (OSAHS) is not precisely defined for children. The primary objective of this study was to...
Detailed Description
Retrospective single center study of 31 children (mean age: 5.5 ± 2.6 years) who benefited from DISE between 2015 and 2018 in the management of OSAHS. Modification of therapeutic management was noted....
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- OSAHS confirmed by overnight sleep monitoring (respiratory polygraphy or overnight polysomnography)
- Exclusion criteria:
- \- Lack of data
Exclusion
Key Trial Info
Start Date :
October 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2018
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03845062
Start Date
October 1 2015
End Date
August 1 2018
Last Update
February 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295